Effects of Immunosuppressive Treatment on Muscle Tissue in Myositis
Author Information
Author(s): Korotkova M, Helmers S Barbasso, Loell I, Alexanderson H, Grundtman C, Dorph C, Lundberg I E, Jakobsson P-J
Primary Institution: Karolinska Institutet
Hypothesis
The study investigates the expression of microsomal prostaglandin E synthase 1 and cyclooxygenases in muscle biopsies from patients with polymyositis or dermatomyositis before and after immunosuppressive treatment.
Conclusion
Conventional immunosuppressive treatment led to a significant downregulation of COX-2 in myositis muscle tissue, while the expression of mPGES-1 and COX-1 remained unchanged.
Supporting Evidence
- Increased expression of mPGES-1, COX-1, and COX-2 was observed in muscle tissue from patients with myositis compared to healthy individuals.
- Conventional immunosuppressive treatment resulted in improved muscle function but still lower than normal.
- A decreased number of CD68-positive macrophages and reduced COX-2 expression in muscle tissue was also seen after treatment.
Takeaway
Doctors looked at muscle samples from people with a disease that makes muscles weak to see how treatment affects certain proteins. They found that while one protein decreased with treatment, others stayed the same.
Methodology
Muscle biopsies were taken from patients and healthy individuals, and the expression of mPGES-1 and COX was evaluated using immunohistochemistry.
Limitations
The study had a small sample size and did not correlate enzyme expression with clinical outcomes effectively.
Participant Demographics
Patients included 9 with recently diagnosed myositis and 3 with treatment-resistant myositis, median age 54 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website